PlainRecalls
FDA Drug Low Class III Terminated

Foradil Aerolizer (formoterol fumarate inhalation powder), 12 mcg per capsule, 60 Capsules, Rx only, Manufactured for: Merck, Sharpe & Dohne Corp., a subsidiary of Merck & Co., Inc. Whitehouse Station, NJ 08889, Manufactured by: Novartis Pharma AG Basle, Switzerland NDC 0085-1401-01

Reported: June 25, 2014 Initiated: May 28, 2014 #D-1387-2014

Product Description

Foradil Aerolizer (formoterol fumarate inhalation powder), 12 mcg per capsule, 60 Capsules, Rx only, Manufactured for: Merck, Sharpe & Dohne Corp., a subsidiary of Merck & Co., Inc. Whitehouse Station, NJ 08889, Manufactured by: Novartis Pharma AG Basle, Switzerland NDC 0085-1401-01

Reason for Recall

Failed Stability Specification; out of specification result for particle size distribution during stability testing

Details

Units Affected
Lot F0067: 45,834 units; Lot F0079: 63,321 units
Distribution
Nationwide
Location
Suffern, NY

Frequently Asked Questions

What product was recalled?
Foradil Aerolizer (formoterol fumarate inhalation powder), 12 mcg per capsule, 60 Capsules, Rx only, Manufactured for: Merck, Sharpe & Dohne Corp., a subsidiary of Merck & Co., Inc. Whitehouse Station, NJ 08889, Manufactured by: Novartis Pharma AG Basle, Switzerland NDC 0085-1401-01. Recalled by Novartis Pharmaceuticals Corp.. Units affected: Lot F0067: 45,834 units; Lot F0079: 63,321 units.
Why was this product recalled?
Failed Stability Specification; out of specification result for particle size distribution during stability testing
Which agency issued this recall?
This recall was issued by the FDA Drug on June 25, 2014. Severity: Low. Recall number: D-1387-2014.